{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:18:17Z","timestamp":1784193497101,"version":"3.55.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.ijantimicag.2006.10.019","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T11:18:11Z","timestamp":1175167091000},"page":"518-527","source":"Crossref","is-referenced-by-count":23,"title":["Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial"],"prefix":"10.1016","volume":"29","author":[{"given":"Joseph R.","family":"DiPersio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Dowzicky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2006.10.019_bib1","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/AAC.47.5.1672-1680.2003","article-title":"Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.diagmicrobio.2005.06.010","article-title":"Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates","volume":"52","author":"Fritsche","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib3","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dki117","article-title":"In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART)","volume":"55","author":"Paterson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib4","first-page":"570","article-title":"Prevalence of extended spectrum beta-lactamase among multidrug resistant Gram-negative isolates from a general hospital in Saudi Arabia","volume":"25","author":"Kader","year":"2004","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/jac\/dki388","article-title":"High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK","volume":"56","author":"Corkill","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/dki291","article-title":"Tigecycline: what is it, and where should it be used?","volume":"56","author":"Livermore","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib7","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne, PA: NCCLS, 2003."},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib8","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S16. Wayne, PA: CLSI, 2006."},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib9","unstructured":"Tygacil Product Insert. Philadelphia, PA: Wyeth Pharmaceuticals Inc., 2005:1\u201319 [Online at http:\/\/www.tygacil.com accessed 8th May 2006]."},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.diagmicrobio.2005.10.010","article-title":"Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004)","volume":"54","author":"Rhomberg","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2003-37923","article-title":"Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY antimicrobial surveillance program (1997\u20132001)","volume":"24","author":"Jones","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0732-8893(01)00269-3","article-title":"In vitro antimicrobial activity of GAR-936 tested against antibiotic-resistant Gram-positive blood stream infection isolates and strains producing extended-spectrum beta-lactamases","volume":"40","author":"Biedenbach","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.diagmicrobio.2005.05.002","article-title":"Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit","volume":"52","author":"Sader","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/jac\/dki175","article-title":"Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymixin B and other agents","volume":"56","author":"Bratu","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib15","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/AAC.49.7.3018-3020.2005","article-title":"Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection","volume":"49","author":"Bratu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib16","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/archinte.165.12.1430","article-title":"Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City","volume":"165","author":"Bratu","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib17","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1086\/342577","article-title":"Molecular epidemiology of a citywide outbreak of extended-spectrum \u03b2-lactamase-producing Klebsiella pneumoniae infection","volume":"35","author":"Quale","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib18","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1128\/AAC.45.5.1402-1406.2001","article-title":"Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000","volume":"45","author":"Sahm","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.10.019_bib19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/502306","article-title":"Rapidly rising prevalence of nosocomial multidrug-resistant, Gram-negative bacilli: a 9-year surveillance study","volume":"25","author":"D\u2019Agata","year":"2004","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857907000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T14:50:49Z","timestamp":1546959049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857907000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0924857907000854"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.10.019","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}